The National Institutes of Health is set to announce the approval of four human embryonic stem cell lines that were eligible for federal funding under former US President George W. Bush, but originally deemed ineligible under new rules from the current administration.
One of these lines includes the most widely used line of human embryonic stem cells, H9. With only one Bush-approved line already on the new NIH registry, this marks a step in the right direction for the stem cell research community. "Re-approval of these cell lines will jump start stalled research and clinical development projects that have been on hold since July, 2009," when the new rules from President Barack Obama took effect, Erik Forsberg, executive director of the linkurl:WiCell Research Institute;http://www.wicell.org/ in Madison, Wisconsin, which applied for the approval, told The Scientist in an email. While the new...
 |
Image: Wikimedia commons, Nissim Benvenisty |
Nature BiotechnologyThe Washington PostEditor's note: Since the publication of this story, the four human embryonic stem cell lines from the WiCell Research Institute have been added to the linkurl:NIH stem cell registry,;http://grants.nih.gov/stem_cells/registry/current.htm?sort=dtd as well as nine additional lines from the University of California, Los Angeles, Harvard University, and Stanford University.
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
